What is Touchlight Genetics?
Based in London, Touchlight Genetics is a pioneering biotechnology firm dedicated to the discovery and development of next-generation genetic medicines. Since its inception in 2007, the company has distinguished itself through the creation of the doggybone DNA (dbDNA) vector. This novel, synthetic DNA technology offers a scalable and efficient alternative to traditional plasmid-based manufacturing, positioning Touchlight as a key player in the development of DNA vaccines and advanced gene therapies. By streamlining the production of genetic material, the company addresses significant bottlenecks in the current biopharmaceutical manufacturing landscape, providing a robust foundation for the future of personalized medicine and therapeutic innovation.
How much funding has Touchlight Genetics raised?
Touchlight Genetics has raised a total of $58M across 1 funding round:
Other Financing Round
$58M
Other Financing Round (2021): $58M with participation from Bridford Investments Limited
Key Investors in Touchlight Genetics
Bridford Investments Limited
A private investment firm focused on long-term capital appreciation and strategic support for high-growth companies in the life sciences and technology sectors.
What's next for Touchlight Genetics?
With this recent capital, Touchlight Genetics is well-positioned to accelerate the commercialization of its dbDNA platform. The strategic focus will likely shift toward expanding manufacturing capacity to meet the growing demand for high-quality genetic vectors in the gene therapy market. Furthermore, the company is expected to deepen its collaborative efforts with pharmaceutical partners, leveraging its synthetic DNA technology to expedite the development of novel vaccines and therapeutic candidates. As the firm transitions into a more mature enterprise-level entity, the emphasis will remain on scaling its proprietary technology while maintaining the rigorous quality standards required for clinical-grade genetic medicine production.
See full Touchlight Genetics company page
